Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), engineered for enhanced stability and prolonged receptor engagement. It is currently under investigation for its role in GLP-1 receptor signaling, with applications in studies of glucose metabolism, insulin modulation, and energy balance. This compound is provided strictly for laboratory research purposes and is not approved for human or veterinary use.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), engineered for enhanced stability and prolonged receptor engagement. It is currently under investigation for its role in GLP-1 receptor signaling, with applications in studies of glucose metabolism, insulin modulation, and energy balance. This compound is provided strictly for laboratory research purposes and is not approved for human or veterinary use.